Source: Medicines & Healthcare Products Regulatory Agency (GB) Publisher: neuraxpharm Arzneimittel GmbH, Elisabeth-Selbert-Str.23, 40764, Langenfeld, Germany
Methocarbamol neuraxpharm 750 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White, oblong film-coated tablets with a score line on one side, size: 19.1 ± 0.2 mm x 8.1 ± 0.2 mm. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Each film-coated tablet contains 750 mg methocarbamol.
Excipients with known effect: Each film-coated tablet contains 22.37 mg lactose (as monohydrate) and 0.875 mg soya lecithin.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Methocarbamol |
Methocarbamol is a centrally acting muscle relaxant. Its muscle relaxing action is the result of the inhibition of polysynaptic reflexes in the spinal marrow and subcortical centres. |
| List of Excipients |
|---|
|
Tablet core: Lactose monohydrate Film-coating: Polyvinyl alcohol |
PVC/ACLAR//Al blisters.
Pack sizes:
20, 50 or 100 film-coated tablets.
Not all pack sizes may be marketed.
neuraxpharm Arzneimittel GmbH, Elisabeth-Selbert-Str.23, 40764, Langenfeld, Germany
PL 48035/0023
Date of first authorisation: 11.09.2018
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
